❤️❤️❤️
For patients with IgG4-related disease, there are no approved therapies. Research findings on the efficacy and safety of inebilizumab ― a monoclonal antibody that targets and depletes CD19+ B-cells ― are summarized in a new Quick Take video. nej.md/421enZX
#MedSky #RheumSky
We are excited to announce a new advanced endovascular interventional program starting this July 2025. It is a unique program with shared training between Interventional cardiology and vascular surgery! Contact me at
michael.s.levy@lahey.org to learn more!
🌟Come Join Our Team🌟
🌟2 New Positions, remote/hyrbid🌟
We are looking for skilled Anticoag Pharmacists to grow our Stewardship program. This role will focus on CDTM based outpt mgmt of antithrombotic therapy
#AnticoagStewardship #jobs #pharmacist
jobs.bilh.org/job/burlingt...
